Trials / Completed
CompletedNCT04058015
Outcome of Patients With Thoraco-abdominal Injury and Stress-induced Hyperglycemia or Diabetic Hyperglycemia
Admission Hyperglycemia in Patients With Moderate to Severe Thoracoabdominal Injuries is Associated With Higher Mortality Rate Than Non-Diabetic Normoglycemic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 802 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to measure the effects of SIH and DH on the mortality outcomes of the adult patients with moderate to severe thoracoabdominal injury
Detailed description
Because the pathophysiologic response of the patients with a thoracoabdominal injury is different from those who had a traumatic brain injury, this study aimed to measure the effects of hyperglycemia induced by stress or by diabetes on the outcomes of patients with thoracoabdominal injuries in comparison with those who had non-diabetic normoglycemia (NDN). The primary study hypothesis stated that, following thoracoabdominal injuries, the patients with SIH had a worse outcome than patients with DH. The primary outcome was mortality rate of these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Stress-induced hyperglycemia | Stress-induced hyperglycemia (SIH)was defined as a serum glucose ≥ 200 mg/dL in the patients without Diabetes mellitus. |
| OTHER | Diabetic hyperglycemia | Diabetic hyperglycemia (DH) which indicated a serum glucose ≥ 200 mg/dL in patients with Diabetes mellitus. |
| OTHER | Diabetic normoglycemia | Diabetic normoglycemia (DN), which was defined when there was a serum glucose \< 200 mg/dL in the patients with Diabetes mellitus. |
| OTHER | Non-diabetic normoglycemia | Non-diabetic normoglycemia (NDN) indicating a serum glucose \< 200 mg/dL in patients who were absent of Diabetes mellitus. |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2019-07-01
- Completion
- 2019-08-09
- First posted
- 2019-08-15
- Last updated
- 2019-08-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04058015. Inclusion in this directory is not an endorsement.